George "Trip" Zorn III, MD

Medical School, University of Alabama, Birmingham, Alabama
Residency, Vanderbilt University Medical Center, Nashville, Tennessee
Fellowship, University of Virginia, Charlottesville, Virginia (Cardiothoracic Surgery)

Clinical Interests

  • Cardiac Valve Repair
  • Heart Valve Surgery
  • Aortic Aneurysm
  • Thoracic Aneurysm Surgery
  • Lung Cancer Surgery
  • Heart Rhythm Problems
  • Cardiac Valve Replacement
  • Coronary Artery Disease Surgery
  • Cardiothoracic Surgery
  • Cardiovascular Surgery
  • Hypertrophic Cardiomyopathy
  • Thoracic Surgery

Research Interests

  • Heart Rhythm Problems
  • Aneurysm Repair
  • Cardiac Valve Replacement
  • Cardiovascular Surgery
  • Hypertrophic Cardiomyopathy

Research Projects
Active projects

  • A study of Comparison of the endovascular aortic valve replacement vs surgical replacement sponsored by Medtronic.
  • Continued access study for extreme risk patients sponsored by MDT.
  • TAVI in high surgical risk patients sponsored by Medtronic.
  • TAVI in intermediate surgical risk patients sponsored by Medtronic.
  • Study to learn if the Evolut R study device and the system used to implant it are safe and effective ways of treating aortic stenosis in patients who cannot have an open-heart surgery.
  • Study to learn if the Model 11000M valve is still safe, tolerable, and effective with the new modifications to tissue processing, valve sterilization, and packaging.
  • Study to learn if a device called the Lotus Valve System is a safe and effective treatment for patients with aortic stenosis related to their aortic valve disease.



  • Suzanne Arnold; Matthew Reynolds; Kaijun Wang; Elizabeth Magnuson; Suzanne Baron; Khaja Chinnakondepalli; Michael Reardon; Peter Tadros; George Zorn; Brijeshwar Maini; Mubashir Mumtaz; John Brown; Robert Kipperman; David Adams; Jeffrey Popma; David Cohen. Health status after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the corevalve us pivotal trial. J Am Coll Cardiol. 2015;65(10_S):.  doi:10.1016/S0735-1097(15)61999-4.



Last modified: Aug 27, 2015

George “Trip” Zorn III, MD


George "Trip" Zorn III, MD